Tafasitamab (Monjuvi)

From HemOnc.org - A Hematology Oncology Wiki
(Redirected from MOR208)
Jump to navigation Jump to search

Mechanism of action

Anti-CD19 antibody with an engineered Fc region to enhance Fcγ receptor binding affinity

Diseases for which it is used

History of changes in FDA indication

Also known as

  • Code names: MOR208, MOR00208, XmAb5574
  • Generic name: tafasitamab-cxix
  • Brand name: Monjuvi